MRGE, Merge Healthcare Inc.

** In the fourth quarter 2011, MRGE's revenue grew to $64.1 million ($65.1 million on a pro forma basis), a 39% increase compared to $46.2 million ($51.1 million on a pro forma basis) in the same period the prior year.

Adjusted EBITDA was $15.1 million, representing 23% of pro forma revenue in the quarter compared to $13.3 million and 26% in the fourth quarter of 2010.

MRGE is a leading provider of enterprise imaging and interoperability solutions. Merge solutions facilitate the sharing of images to create a more effective and efficient electronic healthcare experience for patients and physicians.

More about MRGE at www.merge.com.

************

TSRX, Trius Therapeutics, Inc.

** TSRX reported the issuance of Patent # 908206 by the State Intellectual Property Office of the People's Republic of China (PRC) that protects the composition of matter of TSRX's Phase 3 investigational-drug, tedizolid phosphate, through 2024. In addition to the issuance in China, patents for tedizolid phosphate have also issued in other jurisdictions including Australia, Canada, Europe, India, Japan, Mexico, Russia and the United States.

TSRX licensed the rights to tedizolid phosphate for Asia-Pacific and emerging markets to Bayer Pharmaceuticals and recently announced receiving a $5 million milestone payment from Bayer after the successful completion of the "112" Phase 3 clinical study of tedizolid phosphate in acute bacterial skin and skin structure infections (ABSSSI). TSRX retains the rights to tedizolid in the U.S., Canada and the EU countries.

TSRX is a biopharmaceutical company focused on the discovery, development and commercialization of innovative antibiotics for life-threatening infections.

More about TSRX at www.triusrx.com.

************

AEA, Advance America, Cash Advance Centers Inc.

** AEA and Grupo Elektra, S.A.B. de C.V. reported that AEA and subsidiaries of Grupo Elektra have entered into a definitive agreement under which Grupo Elektra will acquire control of all of the outstanding shares of AEA for $10.50 per share in cash. The total transaction value is approximately $780 million, including the Company's outstanding debt as of December 31, 2011.

Grupo Elektra is Latin America's leading specialty retailer and financial services company focused on the underserved market.

AEA is the leading provider of non-bank cash advance services in the United States, with approximately 2,600 centers in 29 states, the United Kingdom, and Canada.

More about AEA at www.advanceamerica.net

**************************************************************

********************************

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. PennyOmega.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold PennyOmega.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://pennyomega.com/disclaimer). Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (CRWE.OB) is a media-advertisement and newswire company. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period.